SHLP6 — Indexed Studies

Optimizing care for patients with maxillomandibular Gorham-Stout disease.

Hennocq Q, Donadieu J, Bouaoud J et al.

Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation.

Maas-Bauer K, Meyer T, Yücel M et al.

Pre-operative circulating tumor cells predict worse treatment outcome in patients with high-grade serous ovarian cancer.

Lobermeyer A, Schöllhorn JS, Rademacher PN et al.

Microbiota biomarkers as predictors on immunotherapy response in patients with advanced non-small cell lung cancer.

Vicente-Valor J, Aguado C, Mateos M et al.

A first-in-human phase I clinical trial investigating the safety and efficacy of repeat dosing MSCTRAIL cell therapy in addition to chemotherapy and immunotherapy in patients with advanced lung cancer.

Graham RN, Davies A, Mullin ML et al.

Discovery of Autophagy Modulators that Increase I1061T NPC1 Expression and Promote Cholesterol Efflux in Niemann-Pick Type C Patient-Derived Fibroblasts.

Salkovski M, Arrieche Suarez A, Gao Q et al.

Complications After Rectal Cancer Surgery: Do Female Patients Fare Better? A Retrospective, Matched Cohort Analysis.

Damanakis AI, Dieplinger G, Ernst A et al.

The Pharmacokinetics and Relative Bioavailability of a Mini-Tablet of Mercaptopurine, a Novel Formulation for Use in Children with Acute Lymphoblastic Leukemia.

Chen Z, Zheng YY, Liu QL et al.

BRAF (V600E) Metastatic Synovial Sarcoma Treated with BRAF & MEK Inhibitors Achieves Complete Response. A Case Report & Literature Review.

Burg D, Babkoff A, Or O et al.

Association between sleep quality and cancer-related cognitive impairment in patients with cancer: a meta-analysis.

Dang Z, Fan M, Zhang Y et al.

Reduced postprandial lipid accumulation in circulating monocytes by olezarsen attenuates pro-inflammatory changes in hypertriglyceridemic patients.

Peletier MC, Kraaijenhof JM, Versloot M et al.

Elevated TNF-α level is correlated with NF-κB/p65 activation in patients with sporadic colorectal cancer.

Santana-Bejarano UF, Fernandez-Sanchez D, Bobadilla-Morales L et al.

Long-term culture of patient-derived pheochromocytoma organoids.

van den Berg MF, Timmermans-Sprang EPM, Zethof J et al.

How to talk about death? A cross-sectional survey on patients', informal caregivers' and health care professionals' views in the setting of allogenic hematopoietic stem cell transplantation.

Preuss L, Simon ST, Herling M et al.

Role of Complement Component 9 in Bone Health: Causal Evidence in Humans and Mechanistic Studies in Mice.

Ohlsson C, Törnqvist AE, Nilsson KH et al.

Proximity-Induced Transfer of a Mass Tag Enables Direct Profiling of Active Matrix Metalloproteases.

Berthy L, Pasco U, Sejalon-Cipolla M et al.

Orthotopic Esophageal Cancer Xenograft Model in Immunosuppressed Microminipigs for Near-Infrared Fluorescence Endoscopy.

Miyake T, Kawano Y, Kashihara T et al.

RNA-Centric Tumour Evolution: Transcriptional Reinforcement, Reversibility, and Clinical Plasticity Beyond Genetics.

Singh N

Frequent RBM10 Comutation and a Mutually Exclusive Relationship With Other TP53 Pathway Aberrations in Early-Stage Non-Small-Cell Lung Cancer with EGFR Mutation.

Suda K, Sakai K, Ito M et al.

Pharmacological inhibition of transforming growth factor-β activated kinase 1 (TAK1) prevents chemotherapy induced peripheral neuropathy (CIPN).

Haystead T, Giuvelis D, Freeze R et al.

Topical Combined 5-Fluorouracil & Calcipotriene for Actinic Keratosis and Superficial Keratinocyte Carcinoma: Modified Delphi Expert Panel Guidelines from ITSCC.

Loranger N, Trepanowski N, Shah P et al.

Fortilin binds and stabilizes MEF2C, activates it through phosphorylation, and drives transcription of the cell structural and survival protein CTNNA3.

Nakashima M, Mukherjee S, Pinkaew D et al.

Lactylome Reprogramming Mediates Therapeutic Response and Adaptation to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma.

Peng P, Cen X, Wang T et al.

Targeting the aHSC-PGE(2)-NK cell axis overcomes immunosuppression and inhibits liver metastasis in fibrotic liver.

Tang JJ, Chen C, Guan ZY et al.

Cimigenoside enhances Taxol chemosensitivity in triple-negative breast cancer via the γ-secretase/RBPJ-PXR axis.

Feng M, Yang X, Yao K et al.

MiR-142-3p promotes radioresistance by targeting FOXO4 in colorectal cancer.

Wang X, Hua WX, Liu Y et al.

Ancestral protein reconstruction reveals the mechanism of substrate specificity in FN3K-mediated deglycation.

Matlack JK, Miner RE 3rd, Lokhandwala J et al.

BMAL2 is a druggable target for ovarian clear cell carcinoma (OCCC).

Tan GYT, Lin PY, Cheng LT et al.

Benchmarking alignment methods for spatial transcriptomics data.

Yan Y, Gu T, Sun C et al.

Irisin ameliorates obesity and insulin resistance via adipose tissue IL-33 and regulatory T cells.

A M, Wang G, Zammit NW et al.

The exposome of brain aging across 34 countries.

Legaz A, Moguilner S, Barttfeld P et al.

Tumor habitat analysis using multiparametric MRI as a noninvasive correlate of longitudinal changes in telomerase activity in recurrent IDH-wildtype glioblastoma.

Jeong SY, Lee J, Choi Y et al.

Response to Kawamoto et al.

Johmura Y, Wang TW, Nakanishi M

A deep learning approach to assess transendothelial cell trafficking performance.

Schumacher TM, Gottloeber EM, Koziel E et al.

Profiling KRAS mutations in whole blood by error-corrected maximum depth sequencing.

Ramaker RC, Zhang Y, Strickler JH et al.

In silico design of a multiepitope vaccine against antibiotic drug-resistant Acinetobacter baumannii.

Khadka S, Khan MA, Iqbal S et al.

Phosphorylated lantibiotics-producing commensals integrate into the human oral microbiome to suppress pathogens and promote microbiome homeostasis.

Barbour A, Bendayan Y, Marks C et al.

Distinct mechanisms of replication stress induced by oncogenic RAS and cyclin E1 converge on R-loop-dependent fork reversal.

Oravetzova A, Dvorakova M, Mihai AI et al.

TGF-α/EGFR-mediated lymphatic metastasis reveals a repositionable therapeutic target in breast cancer.

Shi W, Pan Y, Rathod B et al.

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Williamson C, Moodley C, Magaret CA et al.

ESTRO-EORTC expert guideline on target delineation and radiotherapy details for stage I-III small cell lung cancer.

Levy A, Péchoux CL, Grønberg B et al.

Crystal structure, glycan specificity, and induction of cellular stress by the legume lectin DmegA.

Osterne VJS, Ervijn L, Oliveira MV et al.

Genome-wide profiling identifies the genetic dependencies of cell death following EGFR inhibition.

Porto SA, Birdsall GA, Harper NW et al.

Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment.

Maltez VI, Arora C, Gribbin KP et al.

A snapshot of the earliest stages of hepatocellular carcinoma.

Andrades Á, Korbel JO

The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer.

Hubbi ME, Wang CL, Suhail Y et al.

Precision from broad strokes: How the non-specific interactions of metabolites and macromolecules can regulate biology.

Emmons-Bell M, Schvartzman JM

Migrasome-mediated clearance of excess PLK4 defines a targetable vulnerability.

Ma J, Guo Y, Jiang Y et al.

Autoimmune modulation of immune-endocrine-metabolic regulation of ovarian reserve: A cohort study of 803 women.

Han AR, Alzahrani M, Luu TV et al.

Single-cell transcriptomics reveal PRRC1 as a malignant cell enriched driver of DNA repair and therapy resistance in glioblastoma.

Kumar S, Tsai MC, Solomon DD et al.